These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26098477)

  • 1. Successful Management of Type 2 Diabetes with Lifestyle Intervention: A Case Report.
    Liebhauser M; Ofner M; Mittermayer F
    Int J Vitam Nutr Res; 2014; 84(3-4):133-9. PubMed ID: 26098477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful strategy to improve glucose tolerance in Thai obese youth.
    Numbenjapon N; Nakavachara P; Santiprabhob J; Kiattisakthavee P; Wongarn R; Likitmaskul S
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S131-8. PubMed ID: 21280526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of lifestyle interventions in patients with type 2 diabetes: A systematic review and meta-analysis.
    Huang XL; Pan JH; Chen D; Chen J; Chen F; Hu TT
    Eur J Intern Med; 2016 Jan; 27():37-47. PubMed ID: 26655787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin.
    Kashi Z; Mahrooz A; Kianmehr A; Alizadeh A
    PLoS One; 2016; 11(3):e0151543. PubMed ID: 26978661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease.
    Nar A; Gedik O
    Acta Diabetol; 2009 Jun; 46(2):113-8. PubMed ID: 18839053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Skills for Change Program on metabolic control, diet and physical activity levels in adults with type 2 diabetes: A cluster randomized trial.
    Ali HI; Al Ketbi LB; Platat C; Abdl El Baki H; Elmi F; Ibrahim W; Zoubeidi T; Al Dhaheri AS; Cheikh Ismail L; Tariq MNM; Souka U; Yasin J; Stojanovska L
    PLoS One; 2024; 19(5):e0304639. PubMed ID: 38820345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2015 Jan; 38(1):51-8. PubMed ID: 25336746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin.
    Wilding JP; Leonsson-Zachrisson M; Wessman C; Johnsson E
    Diabetes Obes Metab; 2013 Aug; 15(8):750-9. PubMed ID: 23464532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial.
    Relimpio F; Pumar A; Losada F; Mangas MA; Acosta D; Astorga R
    Diabet Med; 1998 Dec; 15(12):997-1002. PubMed ID: 9868971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.
    McInnes N; Hall S; Sultan F; Aronson R; Hramiak I; Harris S; Sigal RJ; Woo V; Liu YY; Gerstein HC
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32403130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    Ikramuddin S; Korner J; Lee WJ; Thomas AJ; Connett JE; Bantle JP; Leslie DB; Wang Q; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Billington CJ
    JAMA; 2018 Jan; 319(3):266-278. PubMed ID: 29340678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.
    Bulatova N; Kasabri V; Qotineh A; Al-Athami T; Yousef AM; AbuRuz S; Momani M; Zayed A
    Diabetes Metab Syndr; 2018 May; 12(3):257-267. PubMed ID: 29221717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of diabetes in type 2 diabetic patient treated with IFN-alpha and ribavirin for hepatitis C.
    Tahrani A; Bowler L; Singh P; Coates P
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):291-3. PubMed ID: 16462544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups.
    Durán A; Martín P; Runkle I; Pérez N; Abad R; Fernández M; Del Valle L; Sanz MF; Calle-Pascual AL
    J Diabetes; 2010 Sep; 2(3):203-11. PubMed ID: 20923485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a continuous diabetes lifestyle intervention program on male workers in Korea.
    Kang JY; Cho SW; Sung SH; Park YK; Paek YM; Choi TI
    Diabetes Res Clin Pract; 2010 Oct; 90(1):26-33. PubMed ID: 20621377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.